Abstract
The spreading of infectious diseases including COVID-19 depends on human interactions. In an environment where behavioral patterns and physical contacts are constantly evolving according to new governmental regulations, measuring these interactions is a major challenge. Mobility has emerged as an indicator for human activity and, implicitly, for human interactions. Here we study the coupling between mobility and COVID-19 dynamics and show that variations in global air traffic and local car traffic mobility can be used to stratify different disease phases. Our study shows that, for 26 European countries, maximal correlation between driving mobility and disease dynamics follows a normal distribution with a 17-day mean and two-day standard deviation. Our findings suggests that local mobility can serve as a quantitative metric to forecast future reproduction numbers and identify the final stages of the pandemic when mobility and reproduction become decorrelated.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by a Stanford Bio-X IIP seed grant to Ellen Kuhl, by a DAAD Fellowship to Kevin Linka, and by the Engineering and Physical Sciences Research Council grant EP/R020205/1 to Alain Goriely.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
n/a
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
n/a
